Vicarious Surgical Income Statement (2020-2025) | RBOT

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
3.61M4.01M0.84M1.57M1.40M10.05M1.91M1.84M13.36M1.67M1.40M8.47M9.97M1.20M10.80M0.98M9.41M0.35M7.99M
Selling, General & Administrative (Quarter)
1.40M2.28M2.53M7.00M6.93M7.76M8.13M6.89M7.00M7.08M6.91M5.87M5.00M5.59M5.75M5.54M5.29M4.12M3.16M
Restructuring Costs (Quarter)
0.13M1.51M
Other Operating Expenses (Quarter)
0.10M0.33M5.19M9.26M8.34M1.31M12.12M11.88M1.96M12.71M-8.31M66.33M1.14M10.92M-17.21M8.46M1.04M9.05M-11.60M
Operating Expenses (Quarter)
5.23M6.61M8.56M17.82M18.18M19.13M22.16M20.61M22.32M21.46M0.00M80.66M16.11M17.71M-0.66M14.98M15.75M13.52M-0.45M
Operating Income (Quarter)
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
EBIT (Quarter)
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
Non-operating items
Non Operating Investment Income (Quarter)
0.07M0.01M0.07M-0.20M0.04M0.10M-0.05M-0.01M0.17M-0.07M-0.03M-0.02M
Interest & Investment Income (Quarter)
0.00M0.00M-0.00M0.02M0.01M0.10M0.49M0.83M0.07M1.04M0.95M0.97M0.97M0.92M0.80M0.59M0.45M0.26M0.01M
Other Non Operating Income (Quarter)
-19.57M-1.59M0.09M-0.04M
Non Operating Income (Quarter)
0.35M
Net income details
EBT (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Profit After Tax (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.86M-15.33M-15.70M-13.01M-17.05M-15.21M-16.92M-13.89M-15.43M-13.23M-11.05M
Income from Non-Controlling Interests (Quarter)
-21.03M
Income from Continuing Operations (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Consolidated Net Income (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Income towards Parent Company (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Net Income towards Common Stockholders (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Additional items
EPS (Basic) (Quarter)
-1.79-2.27-34.3416.4810.00-0.36-6.09-2.75-6.40-3.62-3.04-2.69-2.90-2.59-2.90-2.37-2.60-2.23-1.86
EPS (Diluted) (Quarter)
-1.79-2.27-14.686.7610.61-0.36-6.09-2.63-6.40-3.62-3.04-2.69-2.90-2.59-2.90-2.37-2.60-2.23-1.86
Shares Outstanding (Quarter)
2.92M2.93M1.31M1.32M4.25M4.04M4.07M4.06M4.20M4.23M5.17M4.87M5.86M5.87M5.90M5.89M5.92M5.94M5.95M5.95M
Shares Outstanding (Diluted) (Quarter)
2.92M2.93M3.07M3.22M4.01M4.04M4.07M4.25M4.20M4.23M5.17M4.87M5.86M5.87M5.90M5.89M5.92M5.94M5.95M5.95M
Shares Outstanding (Entity) (Quarter)
2.92M2.93M1.31M1.32M4.25M4.04M4.07M4.06M4.20M4.23M5.17M4.87M5.86M5.87M5.90M5.89M5.92M5.94M5.95M
EBITDA (Quarter)
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
Interest Expenses (Quarter)
0.00M0.01M0.03M0.01M0.26M0.67M0.03M0.35M0.49M15.30M6.50M-1.58M0.56M8.86M2.50M0.58M0.58M2.57M16.96M